903 resultados para Catch all


Relevância:

20.00% 20.00%

Publicador:

Resumo:

kuv., 11 x 14 cm

Relevância:

20.00% 20.00%

Publicador:

Resumo:

kuv., 11 x 14 cm

Relevância:

20.00% 20.00%

Publicador:

Resumo:

kuv., 11 x 14 cm

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Presentation at Open Repositories 2013, DSpace User Group, on 12.7.2013 in Charlottetown, PEI, Canada

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Presentation at Open Repositories 2014, Helsinki, Finland, June 9-13, 2014

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Presentation at Open Repositories 2014, Helsinki, Finland, June 9-13, 2014

Relevância:

20.00% 20.00%

Publicador:

Resumo:

A comparison between two competing models of an all mechanical power transmission system is studied by using Dymola –software as the simulation tool. This tool is compared with Matlab/ Simulink –software by using functionality, user-friendliness and price as comparison criteria. In this research we assume that the torque is balanceable and transmission ratios are calculated. Using kinematic connection sketches of the two transmission models, simulation models are built into the Dymola simulation environment. Models of transmission systems are modified according to simulation results to achieve a continuous variable transmission ratio. Simulation results are compared between the two transmission systems. The main features of Dymola and MATLAB/ Simulink are compared. Advantages and disadvantages of the two softwares are analyzed and compared.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Julkaisussa: Dell' arcano del mare di Ruberto Dudleo ... parte seconda del tomo terzo contenente il libro sesto. Vol III

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Thirty-seven patients with acute promyelocytic leukemia (APL) were treated with all-trans retinoic acid (ATRA). Patients received 45 mg m-2 day-1 po of ATRA until complete remission (CR) was achieved, defined as: a) presence of less than 5% blasts in the bone marrow, with b) white blood cells >103/mm3, c) platelets >105/mm3 and d) hemoglobin concentration >8 g/dl, with no blood or platelet transfusions. Thirty-one (83.7%) patients achieved CR by day 50, and 75% of these before day 30. Correction of the coagulopathy, achieved between days 2 and 10 (mean, 3 days), was the first evidence of response to treatment. Only one patient had been previously treated with chemotherapy and three had the microgranular variant M3 form. Dryness of skin and mucosae was the most common side effect observed in 82% of the patients. Thrombosis, hepatotoxicity and retinoid acid syndrome (RAS) were observed in 7 (19%), 6 (16%) and 4 (11%) patients, respectively. Thirteen (35%) patients had to be submitted to chemotherapy due to hyperleukocytosis (above 40 x 103/mm3) and six of these presented with new signs of coagulopathy after chemotherapy. Four (11%) patients died secondarily to intracerebral hemorrhage (IH) and two (5.4%) dropped out of the protocol due to severe ATRA side effects (one RAS and one hepatotoxicity). RAS and IH were related strictly to hyperleukocytosis. The reduced use of platelets and fresh frozen plasma probably lowered the total cost of treatment. We conclude that ATRA is an effective agent for inducing complete remission in APL patients.